Sacroiliac Joint Fusion: What the Medical Literature Reports on Indications, Techniques, and Outcomes

Sacroiliac joint fusion is a procedure intended to stabilize and fuse the joint between the sacrum and ilium in selected patients with persistent pain attributed to the sacroiliac joint. This article summarizes what peer-reviewed studies, systematic reviews, randomized trials, and current clinical practice report about diagnostic frameworks, patient selection, operative approaches, reported outcomes, complications, and evidence limitations. It is intended as an educational overview and does not evaluate, address, or offer opinion on any individual patient, provider, or matter.

How sacroiliac joint pain is described in the literature

The sacroiliac joint is a load-transmitting articulation at the junction of the spine and pelvis. Published reviews describe pain attributed to the joint as commonly felt in the lower back, buttock, or posterior pelvis, with possible referral into the groin or leg. The symptom distribution overlaps with lumbar disc, facet, hip, and myofascial conditions, so the literature does not treat location alone as a specific diagnosis.

Contemporary diagnostic frameworks generally combine history, physical examination, exclusion of competing pain generators, and a response to image-guided anesthetic injection. Consensus guidance reports that clusters of provocative maneuvers have reasonable sensitivity but lower specificity for intra-articular pathology, while imaging has limited sensitivity for non-inflammatory mechanical sacroiliac joint pain. In the comparative fusion trials, diagnostic confirmation commonly required at least 50% temporary pain relief after an image-guided intra-articular local anesthetic injection.

Patient selection in comparative studies

The best-known randomized evidence comes from the INSITE trial, a prospective, multicenter, unblinded randomized controlled study of minimally invasive lateral transiliac fusion compared with nonsurgical management. The trial enrolled adults with sacroiliac joint dysfunction attributed to degenerative sacroiliitis or sacroiliac joint disruption. Its eligibility framework included pain below the fifth lumbar level or in the buttock or leg, a positive Fortin finger test, pain reproduced by at least three of five provocative tests, at least 50% relief after image-guided injection, and minimum baseline pain and disability scores.

This selection framework is important when interpreting the results. The trial did not represent every person with buttock pain or every form of sacroiliac joint disease. It excluded several competing spinal, inflammatory, metabolic, traumatic, and administrative contexts, and it studied a particular lateral implant system. The later systematic review and meta-analysis of minimally invasive fusion likewise found that the comparative studies it included used image-guided injection to confirm the pain source and focused on lateral transiliac fusion with cannulated triangular titanium implants.

Techniques described in current practice

The literature describes several broad technical families. Lateral transiliac fusion places implants across the sacroiliac joint from the lateral ilium, commonly using fluoroscopy, three-dimensional navigation, or intraoperative CT. The best-developed comparative evidence concerns porous triangular titanium implants intended to provide immediate mechanical stabilization and a surface for bone ongrowth. Posterior intra-articular and posterolateral-oblique procedures use a posterior or oblique corridor and differ in implant design, graft placement, and the amount of joint preparation described by individual systems.

Open fusion and revision procedures also appear in the literature, particularly in older series or complex structural settings. These populations are not interchangeable with the minimally invasive randomized cohorts. Professional and consensus discussions generally emphasize that approach, implant geometry, bone quality, joint anatomy, prior operations, and the presence of competing pain sources affect the procedure studied and the outcomes reported.

What randomized and comparative studies report

In the 12-month INSITE report, minimally invasive fusion produced greater average improvement in sacroiliac joint pain, Oswestry Disability Index scores, and health-related quality of life than nonsurgical management at six months and maintained improvement at twelve months. The trial's composite success endpoint, which combined a pain reduction threshold with absence of device-related serious adverse events, neurologic worsening, and reintervention for sacroiliac joint pain, was also more often achieved in the fusion group. Participants who crossed from nonsurgical care to fusion after six months improved after surgery as well.

A 2022 systematic review and meta-analysis combined two randomized trials and one retrospective comparative cohort. At six months, pooled mean differences favored minimally invasive fusion over conservative management for pain and disability. The review reported greater reductions in visual analog pain scores and Oswestry Disability Index scores, but it also emphasized that the studies were few, samples were generally small, outcomes were subjective, pain scales differed, and all comparative studies used one lateral technique and device family. The results therefore support an average treatment effect in the selected study populations rather than a universal conclusion for every approach or diagnosis.

• —The comparative literature primarily studies adults with persistent sacroiliac-region pain, a compatible examination pattern, and a positive image-guided anesthetic injection.
• —The strongest comparative evidence concerns lateral minimally invasive fusion with triangular titanium implants, not all forms of sacroiliac joint fusion.
• —Reported benefits are most often expressed as changes in pain, disability, and quality-of-life scores rather than as a single radiographic endpoint.
• —Studies differ in conservative-care comparators, crossover rules, follow-up duration, pain scales, and definitions of treatment success.

The published evidence supports improvement after minimally invasive sacroiliac joint fusion in selected study populations, while the strength of conclusions varies by approach, implant, diagnostic framework, and follow-up.

Radiographic fusion, complications, and longer-term outcomes

Radiographic fusion and clinical improvement are related but distinct outcomes. The 12-month randomized report did not yet provide its planned 24-month pelvic CT endpoint. Later prospective follow-up of 3D-printed triangular titanium implants reported sustained pain, disability, and quality-of-life improvement at five years in the subjects available for follow-up, with bone opposed to the implants in all evaluated cases and bridging bone reported in most. That study was single-arm and had follow-up attrition, so it describes durability within a treated cohort rather than proving superiority over another treatment.

Reported complications in comparative series include wound problems, implant malposition, nerve-root irritation, adjacent iliac fracture, recurrent sacroiliac-region pain, and reoperation. The 2022 meta-analysis identified a small number of serious events and revisions, including revisions for implant malposition, but the review cautioned that event counts were limited and definitions were not uniform. Longer-term prospective follow-up has reported few late device-attributable events in its selected cohort, while the broader literature continues to describe implant-specific and approach-specific complications rather than one rate that applies to all procedures.

Evidence for posterior and oblique procedures

Posterior and posterolateral-oblique fusion procedures are represented mainly by prospective and retrospective observational studies. A 2025 systematic review identified twelve eligible publications, including two prospective and ten retrospective studies, with two studies directly comparing posterior or oblique techniques with lateral fusion. Average pain improvement at final follow-up varied across the approach categories, and the authors reported statistically significant improvement in nearly all cohorts. Because the studies used heterogeneous devices, techniques, selection criteria, and follow-up, the review did not perform a formal meta-analysis.

This newer evidence expands the range of procedures described in the literature but does not yet provide the same level of comparative certainty as the lateral randomized trials. The review concluded that randomized controlled studies are needed to clarify approach and device selection and to establish longer-term outcomes. Findings from a posterior or oblique cohort therefore should not be assumed to reproduce the results of a lateral transiliac implant trial.

How the evidence is interpreted in clinical practice

Across professional guidance, systematic reviews, and clinical series, sacroiliac joint fusion is generally discussed as a procedure for a selected subgroup rather than a treatment for nonspecific low-back pain. The recurring clinical questions are whether the symptoms are plausibly generated by the sacroiliac joint, whether competing sources have been considered, whether nonoperative measures have been tried, and which structural and procedural context is represented by the evidence being cited. These are descriptions of how the literature frames the problem, not a universal algorithm or a patient-specific recommendation.

The evidence base also has important commercial and methodological context. Several early comparative studies were sponsored by the implant manufacturer, and the principal randomized trial was unblinded, lacked a sham-surgery control, and allowed crossover. Observational studies of newer approaches are vulnerable to selection bias, loss to follow-up, and differences in outcome measurement. Systematic reviews therefore describe the results as encouraging for selected patients while continuing to identify the need for independent, randomized, longer-term comparisons.

Summary of the published evidence

The published evidence supports several recurring conclusions. First, sacroiliac joint pain is diagnosed through a combination of clinical features, provocative-test patterns, exclusion of competing sources, and — in the fusion trials — meaningful relief after image-guided anesthetic injection; imaging alone has limited sensitivity for mechanical pain. Second, the strongest comparative evidence concerns selected adults with degenerative sacroiliitis or sacroiliac joint disruption treated with lateral minimally invasive fusion using triangular titanium implants. Third, randomized trials and a systematic review report greater average improvements in pain, disability, and quality of life than conservative management in those selected populations. Fourth, radiographic bridging, complications, reoperation, and long-term durability are separate endpoints, and the evidence for posterior, oblique, open, and revision procedures is more observational and heterogeneous. Finally, industry sponsorship, lack of blinding or sham control, crossover, small samples, and technique-specific study populations limit how broadly the findings can be generalized.

This overview is educational. It is not medical advice, does not evaluate any specific patient or matter, and does not substitute for review of the primary peer-reviewed sources.

Frequently asked

Common questions on this topic